Target Health, LifeOnKey Partner To Improve Medical Research
Target Health said that with this contract it can now offer the health care companies with an electronic clinical trial record that can manage and monitor the care
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.
Bioline manufactures and distributes specialised molecular biology reagents for the life science research, biotech, pharmaceutical, and commercial diagnostic markets in Germany, Australia, and the US. Meridian said that,